FDA device listing
BioGX - Lesion HSVHD - OSR for BD MAX
FDA device listing 1364456556 · BioGX
Key facts
| Proprietary names | BioGX - Lesion HSVHD - OSR for BD MAX |
|---|---|
| Owner/operator | BioGX |
| Owner/operator number | 10054546 |
| Product codes | PGI |
| Device names | PGI - Herpes Virus (Vzv, Hsv1, Hsv2), Dna Detection Assay For Cutaneous And Mucocutaneous Lesion Samples |
| Device class | Class II |
| Classification regulations (21 CFR) | 866.3309 |
| Review panels | Microbiology |
| Registered establishments | BIOGX |
| Establishment registrations | 3010749841 |
| FEI numbers | 3010749841 |
| Establishment operations | U.S. Manufacturer of Export Only Devices |
| Registration valid through | 2026 |
At a glance
- 1–9 Registered establishments listing this device
- None listed Premarket submission listed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA device listings
Establishments that make or process devices for the U.S. market must list each device with the FDA. A listing records the device's proprietary names, product codes and premarket submission, and every registered establishment that handles it.
Source: U.S. Food and Drug Administration (FDA), Establishment Registration and Device Listing database